Overview

Basal Plus GLP1-ra on Glycemic Variability in CKD

Status:
Not yet recruiting

Trial end date:
2025-01-03

Target enrollment:

Participant gender:

Summary

To compare GLP-1 RA plus basal insulin (BGLP) versus basal-bolus (BB) insulin regimens on glycemic variability (GV) and time in range (TIR) in diabetes patients CKD stage 3-4

Phase:

Phase 4

Details

Lead Sponsor:

Elaine Chow

Treatments:

Dulaglutide